Chr. Olesen Synthesis Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$11.2M
- Investors
-
1
Chr. Olesen Synthesis General Information
Description
Operator of a pharmaceutical company intended to provide controlled substances comprising semi-synthetic opioids. The company's ingredients are focused on controlled substances and molecules like buprenorphine, codeine phosphate, dexamfetamine, hydromorphone, and lisdexamfetamine and also offer an election of other APIs like pramipexole, risedronate, terbinafine, and tolfenamic acid as well as advanced intermediates, enabling pharmaceutical clients to avail advanced intermediates.
Contact Information
Website
www.cosynthesis.dk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
- Kanalholmen 8-12
- 2650 Hvidovre
- Denmark
+45 36 00 00 00
Chr. Olesen Synthesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 06-Oct-2015 | $11.2M | 000.00 | Completed | Generating Revenue |
Chr. Olesen Synthesis Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Moestrup | Chief Executive Officer & Managing Director | ||
| Lone Nielsen | Manager, Finance & Administration |
Chr. Olesen Synthesis Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Gale | Signet Healthcare Partners | Board Member | 000 0000 |
| Mads Olesen | Self | Chairman | 000 0000 |
Chr. Olesen Synthesis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Chr. Olesen Synthesis Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Signet Healthcare Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 |
Chr. Olesen Synthesis Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 01-Jan-2011 | 00000 0000 | Distributors (Healthcare) |
Chr. Olesen Synthesis Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000 | 01-Jan-2011 | 00000 00000 00 | Completed |
|